Last Close
May 15  •  04:00PM ET
0.2760
Dollar change
+0.0080
Percentage change
2.99
%
Index
-
P/E
-
EPS (ttm)
-0.17
Insider Own
65.66%
Shs Outstand
7.37M
Perf Week
-1.39%
Market Cap
2.03M
Forward P/E
-
EPS next Y
-
Insider Trans
0.00%
Shs Float
7.37M
Perf Month
-20.69%
Enterprise Value
-0.01M
PEG
-
EPS next Q
-
Inst Own
0.41%
Perf Quarter
-35.81%
Income
-3.58M
P/S
50.75
EPS this Y
-
Inst Trans
-6.22%
Perf Half Y
-63.20%
Sales
0.04M
P/B
1.51
EPS next Y
-
ROA
-90.82%
Perf YTD
-31.02%
Book/sh
0.18
P/C
0.84
EPS next 5Y
-
ROE
-1082.72%
52W High
9.50 -97.09%
Perf Year
-94.15%
Cash/sh
0.33
P/FCF
-
EPS past 3/5Y
-65.95% -74.96%
ROIC
-85.52%
52W Low
0.22 25.45%
Perf 3Y
-
Dividend Est.
-
EV/EBITDA
-
Sales past 3/5Y
-2.38% -3.22%
Gross Margin
-54.48%
Volatility
22.11% 11.45%
Perf 5Y
-
Dividend TTM
-
EV/Sales
-0.25
EPS Y/Y TTM
-208.87%
Oper. Margin
-9692.62%
ATR (14)
0.04
Perf 10Y
-
Dividend Ex-Date
-
Quick Ratio
2.35
Sales Y/Y TTM
6.30%
Profit Margin
-9376.19%
RSI (14)
45.31
Recom
-
Dividend Gr. 3/5Y
- -
Current Ratio
2.35
EPS Q/Q
-223.92%
SMA20
-0.87%
Beta
2.07
Target Price
-
Payout
-
Debt/Eq
0.10
Sales Q/Q
277.69%
SMA50
-16.19%
Rel Volume
0.16
Prev Close
0.27
Employees
10
LT Debt/Eq
0.07
Earnings
-
SMA200
-74.00%
Avg Volume
2.15M
Price
0.28
IPO
Apr 10, 2025
Option/Short
No / Yes
EPS/Sales Surpr.
- -
Trades
Volume
343,792
Change
2.99%
Mar-11-26 08:30AM
Dec-09-25 08:30AM
Dec-05-25 03:14PM
Nov-28-25 08:30AM
Nov-18-25 08:30AM
08:40AM Loading…
Oct-27-25 08:40AM
Oct-06-25 08:30AM
Sep-09-25 08:05AM
Aug-18-25 08:00AM
Jul-21-25 09:00AM
Jun-30-25 08:00AM
Jun-04-25 08:00AM
May-08-25 01:05PM
May-06-25 10:45AM
May-05-25 12:29PM
12:27PM Loading…
12:27PM
12:24PM
Apr-12-25 01:30AM
Apr-11-25 11:07AM
Apr-10-25 08:35AM
Cuprina Holdings (Cayman) Ltd. engages in the manufacturing, sale, and supply of medical devices to manage and accelerate healing and closure of chronic wounds. Its products include nature-based bioactive, in the form of advanced wound dressings, derived from sustainable sources. The company was founded by Carl Marc Baptista on August 28, 2019 and is headquartered in Singapore.
CEO & DirectorMr. Yong Qi Quek
Chief Financial OfficerMr. Tat Jing Chan
Medical & Scientific DirectorDr. Ronald Sherman